In the U.S. today there are 27 FDA approved cell and gene therapies, with more than 2,000 therapies in development worldwide. Just as the biologic landscape has evolved over the last decade, so too will cell and gene therapy. The comprehensive one-day workshop will review the pipeline, explore the patient experience and ways to optimize the patient journey, discuss the role for specialty pharmacy, and examine coverage and unique benefit designs through a combination of roundtable, panel discussion, and speaker led sessions.

8:00 a.m.
The Cell and Gene Therapy Basics by Shawn Francis, PharmD, Director of Specialty Pharmacy at Children's National Hospital

2:00 p.m.

Legislative Topics and Managing Risk panel moderated by Shawn Francis, PharmD, Director of Specialty Pharmacy at Children's National Hospital

3:00 p.m.

Current Practices in Demonstrating Value panel including Alex Pham, PharmD, Vice President of Client Strategy

Clinical and financial impact of clinical pharmacist intervention in a rural, integrated health system specialty pharmacy
by Maria Wuerch, PharmD, Clinical Specialty Pharmacist, Clearway Health

Impact of implementing a pharmacist-led system-wide hepatitis C screening and test-to-treat program
‍by Michelle Coady, PharmD, Director of Specialty Pharmacy, Clearway Health

Leveraging migraine patient reported outcomes data to develop targeted pharmacist interventions
by Shawn Stanford, PharmD, Regional Director of Specialty Pharmacy Operations

Values and pitfalls of using Routine Assessment of Patient Index Data 3 (RAPID3) aggregate scores in making clinical interventions in patients with Rheumatoid Arthritis
by Aman Kehasse, PharmD, Clinical Programs Manager, Clearway Health

Optimizing HIV pre-exposure prophylaxis services in primary care settings: pharmacist-led performance improvement program
by Aman Kehasse, PharmD, Clinical Programs Manager, Clearway Health

Immunization screening prior to initiation of immune modulating medications: a multi-site study
by Aman Kehasse, PharmD, Clinical Programs Manager, Clearway Health

Beyond viral load suppression: role of health system specialty pharmacy in HIV management and opportunistic infections prevention
by Aman Kehasse, PharmD, Clinical Programs Manager, Clearway Health

Amanuel Kehasse, Clinical Programs Manager at Clearway Health will share his experience on how specialty pharmacists can play a key role in driving a shared decision-making process, therapeutic monitoring and driving better patient outcomes when treating Systemic Lupus Erythematosus and Lupus Nephritis.